{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:50:49Z","timestamp":1787878249627,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Society for Women's Health Science Research of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary epithelial ovarian carcinoma\u00a0is sub-classified into serous, mucinous, endometrioid and clear cell subtypes. Neoadjuvant chemotherapy\u00a0has become an alternative treatment option past several years, as serous\u00a0carcinoma, the most common subtype, is known as chemotherapy-sensitive tumor. On the other hand,\u00a0mucinous and clear cell carcinoma are known as chemotherapy-resistive. Therefore, it may be meaningful to estimate subtype of ovarian carcinoma using imaging modality. The purpose of this study is to study whether CT or MRI can determine the subtypes of epithelial ovarian cancers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The imaging and clinical findings obtained from 125 consecutive patients with primary ovarian carcinoma were retrospectively analyzed. Forty-four of the patients had serous carcinoma; 13, mucinous carcinoma; 53, clear cell carcinoma; and 15, endometrioid carcinoma. We studied the bilateralism, morphological type, tumor diameter, solid portion ratio, relative signal intensity on T2WI and DWI, contrast ratio, and endometriosis on MRI and the calcification, peritoneal dissemination and lymph node metastasis, clinical staging, and thromboembolism on CT. We also studied the tumor markers and serum calcium concentrations. Each parameter was statistically analyzed by univariate and multivariate analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Serous carcinoma showed a significantly higher incidence of bilateral disease, smaller tumor size, higher signal intensity on DWI, and less frequent hypercalcemia. The CA19-9 level was significantly higher in mucinous carcinoma, in which most of the tumors appeared as multilocular cystic masses. Clear cell carcinoma appeared as unilateral disease with a larger solid portion and hypercalcemia in younger patients. Endometrioid carcinoma only showed a lower incidence of intraperitoneal dissemination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CT and MRI combined with clinical data especially tumor markers and presence of paraneoplastic syndrome could partly predict epithelial ovarian cancer subtypes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40644-016-0061-9","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T11:45:07Z","timestamp":1455277507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9884-0395","authenticated-orcid":false,"given":"Yumiko Oishi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyomi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Oki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Saida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"61_CR1","unstructured":"World Health Organization. Tumours of the ovary and peritoneum. In: Tavassoli FA, P. D, editors. Pathology and genetics,Tumours of the breast and female genital organs. 3 ed. Lyon: IARC press; 2003. p. 113\u2013216."},{"key":"61_CR2","first-page":"11","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"TA Longacre","year":"2014","unstructured":"Longacre TA, Wells M, Bell DA, Malpica A, Prat J, Ronnet BM. Tumours of the ovary. In: Kurman RJ, Carcangiu ML, Herrington S, Young RH, editors. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: IARC press; 2014. p. 11\u201386.","edition":"4"},{"key":"61_CR3","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","volume":"25","author":"WE Winter 3rd","year":"2007","unstructured":"Winter 3rd WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25:3621\u20137.","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"61_CR4","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","volume":"88","author":"T Sugiyama","year":"2000","unstructured":"Sugiyama T, Kamura T, Kigawa J, Terakawa N, Kikuchi Y, Kita T, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000;88:2584\u20139.","journal-title":"Cancer"},{"key":"61_CR5","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","volume":"99","author":"H Itamochi","year":"2008","unstructured":"Itamochi H, Kigawa J, Terakawa N. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008;99:653\u20138.","journal-title":"Cancer Sci"},{"key":"61_CR6","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, ovarian cancer including fallopean tube cancer and primary peritoneal cancer. Fort Washington, PA: National Conprehensive Cancer Network, Inc.; 2013."},{"issue":"Suppl 6","key":"61_CR7","doi-asserted-by":"publisher","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","volume":"24","author":"JA Ledermann","year":"2013","unstructured":"Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: ESMO. 2013;24 Suppl 6:vi24\u201332.","journal-title":"Ann Oncol: ESMO"},{"key":"61_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943\u201353.","journal-title":"N Engl J Med"},{"key":"61_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1148\/radiology.190.3.8115631","volume":"190","author":"SH Kim","year":"1994","unstructured":"Kim SH, Kim SC, Choi BI, Han MC. Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology. 1994;190:807\u201311.","journal-title":"Radiology"},{"key":"61_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0009-9260(97)80004-9","volume":"52","author":"C Roy","year":"1997","unstructured":"Roy C, Le Bras Y, Mangold L, Saussine C, Tuchmann C, Pfleger D, et al. Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol. 1997;52:437\u201340.","journal-title":"Clin Radiol"},{"key":"61_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1148\/radiology.162.2.3797643","volume":"162","author":"K Nishimura","year":"1987","unstructured":"Nishimura K, Togashi K, Itoh K, Fujisawa I, Noma S, Kawamura Y, et al. Endometrial cysts of the ovary: MR imaging. Radiology. 1987;162:315\u20138.","journal-title":"Radiology"},{"key":"61_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1148\/radiology.180.1.2052726","volume":"180","author":"K Togashi","year":"1991","unstructured":"Togashi K, Nishimura K, Kimura I, Tsuda Y, Yamashita K, Shibata T, et al. Endometrial cysts: diagnosis with MR imaging. Radiology. 1991;180:73\u20138.","journal-title":"Radiology"},{"key":"61_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/archsurg.1925.01120100007001","volume":"10","author":"JA Sampson","year":"1925","unstructured":"Sampson JA. Endometrial carcinoma of the ovary, arising in endometrial tissue in that organ. Arch Surg. 1925;10:1\u201372.","journal-title":"Arch Surg"},{"key":"61_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2214\/AJR.09.2985","volume":"194","author":"YO Tanaka","year":"2010","unstructured":"Tanaka YO, Okada S, Yagi T, Satoh T, Oki A, Tsunoda H, et al. MRI of endometriotic cysts in association with ovarian carcinoma. AJR Am J Roentgenol. 2010;194:355\u201361.","journal-title":"AJR Am J Roentgenol"},{"key":"61_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","volume":"17","author":"H Kobayashi","year":"2007","unstructured":"Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007;17:37\u201343.","journal-title":"Int J Gynecol Cancer"},{"key":"61_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1148\/radiology.158.3.3945732","volume":"158","author":"DG Mitchell","year":"1986","unstructured":"Mitchell DG, Hill MC, Hill S, Zaloudek C. Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology. 1986;158:649\u201352.","journal-title":"Radiology"},{"key":"61_CR17","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2214\/ajr.183.6.01831721","volume":"183","author":"HJ Kim","year":"2004","unstructured":"Kim HJ, Kim JK, Cho KS. CT features of serous surface papillary carcinoma of the ovary. AJR Am J Roentgenol. 2004;183:1721\u20134.","journal-title":"AJR Am J Roentgenol"},{"key":"61_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1259\/bjr\/12716831","volume":"82","author":"GJ Burkill","year":"2009","unstructured":"Burkill GJ, Allen SD, A\u2019Hern RP, Gore ME, King DM. Significance of tumour calcification in ovarian carcinoma. Br J Radiol. 2009;82:640\u20134.","journal-title":"Br J Radiol"},{"key":"61_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1272\/jnms.72.29","volume":"72","author":"S Okada","year":"2005","unstructured":"Okada S, Ohaki Y, Inoue K, Kawamura T, Hayashi T, Kato T, et al. Calcifications in mucinous and serous cystic ovarian tumors. J Nippon Med School: Nippon Ika Daigaku zasshi. 2005;72:29\u201333.","journal-title":"J Nippon Med School: Nippon Ika Daigaku zasshi"},{"key":"61_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Shih IM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol. 2011;42:918\u201331.","journal-title":"Hum Pathol"},{"key":"61_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jmri.22430","volume":"33","author":"YO Tanaka","year":"2011","unstructured":"Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Nishida M, et al. Ovarian serous surface papillary borderline tumors form sea anemone-like masses. J Magn Reson Imaging. 2011;33:633\u201340.","journal-title":"J Magn Reson Imaging"},{"key":"61_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ygyno.2006.05.030","volume":"103","author":"JD Seidman","year":"2006","unstructured":"Seidman JD, Horkayne-Szakaly I, Cosin JA, Ryu HS, Haiba M, Boice CR, et al. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Gynecol Oncol. 2006;103:703\u20138.","journal-title":"Gynecol Oncol"},{"key":"61_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1259\/bjr.72.856.10474509","volume":"72","author":"YO Tanaka","year":"1999","unstructured":"Tanaka YO, Nishida M, Kurosaki Y, Itai Y, Tsunoda H, Kubo T. Differential diagnosis of gynaecological \u201cstained glass\u201d tumours on MRI. Br J Radiol. 1999;72:414\u201320.","journal-title":"Br J Radiol"},{"key":"61_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jmri.20948","volume":"26","author":"Y Okamoto","year":"2007","unstructured":"Okamoto Y, Tanaka YO, Tsunoda H, Yoshikawa H, Minami M. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR. J Magn Reson Imaging. 2007;26:94\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"61_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2214\/ajr.175.5.1751423","volume":"175","author":"YO Tanaka","year":"2000","unstructured":"Tanaka YO, Yoshizako T, Nishida M, Yamaguchi M, Sugimura K, Itai Y. Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR Am J Roentgenol. 2000;175:1423\u201330.","journal-title":"AJR Am J Roentgenol"},{"key":"61_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/02841850701376326","volume":"48","author":"K Sugiyama","year":"2007","unstructured":"Sugiyama K, Takehara Y. Magnetic Resonance Findings of Clear-Cell Adenocarcinofibroma of the Ovary. Acta Radiol. 2007;48:704\u20136.","journal-title":"Acta Radiol"},{"key":"61_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/01.rct.0000220795.45782.1d","volume":"30","author":"HJ Choi","year":"2006","unstructured":"Choi HJ, Lee JH, Seok Lee J, Choi JI, Kang S, Lee S, et al. CT findings of clear cell carcinoma of the ovary. J Comput Assist Tomogr. 2006;30:875\u20139.","journal-title":"J Comput Assist Tomogr"},{"key":"61_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.rct.0000238005.42129.64","volume":"31","author":"T Manabe","year":"2007","unstructured":"Manabe T, Hirose Y, Kiryuu T, Koudo H, Hoshi H. Magnetic resonance imaging of endometrial cancer and clear cell cancer. J Comput Assist Tomogr. 2007;31:229\u201335.","journal-title":"J Comput Assist Tomogr"},{"key":"61_CR29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ygyno.2006.05.051","volume":"103","author":"CS Hwang","year":"2006","unstructured":"Hwang CS, Park SY, Yu SH, Park JY, Park CT, Han KO. Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy. Gynecol Oncol. 2006;103:740\u20134.","journal-title":"Gynecol Oncol"},{"key":"61_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bjc.6603989","volume":"97","author":"T Satoh","year":"2007","unstructured":"Satoh T, Oki A, Uno K, Sakurai M, Okada S, Minami R, et al. High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer. 2007;97:1053\u20137.","journal-title":"Br J Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-016-0061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-016-0061-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-016-0061-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-016-0061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T06:22:42Z","timestamp":1737786162000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-016-0061-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1186\/s40644-016-0061-9","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"assertion":[{"value":"24 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}